» Articles » PMID: 17553422

Depletion of GGA3 Stabilizes BACE and Enhances Beta-secretase Activity

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2007 Jun 8
PMID 17553422
Citations 202
Authors
Affiliations
Soon will be listed here.
Abstract

Beta-site APP-cleaving enzyme (BACE) is required for production of the Alzheimer's disease (AD)-associated Abeta protein. BACE levels are elevated in AD brain, and increasing evidence reveals BACE as a stress-related protease that is upregulated following cerebral ischemia. However, the molecular mechanism responsible is unknown. We show that increases in BACE and beta-secretase activity are due to posttranslational stabilization following caspase activation. We also found that during cerebral ischemia, levels of GGA3, an adaptor protein involved in BACE trafficking, are reduced, while BACE levels are increased. RNAi silencing of GGA3 also elevated levels of BACE and Abeta. Finally, in AD brain samples, GGA3 protein levels were significantly decreased and inversely correlated with increased levels of BACE. In summary, we have elucidated a GGA3-dependent mechanism regulating BACE levels and beta-secretase activity. This mechanism may explain increased cerebral levels of BACE and Abeta following cerebral ischemia and existing in AD.

Citing Articles

Identification of a novel caspase cleavage motif AEAD.

Fang Y, Gong Z, You M, Peng K Virol Sin. 2024; 39(5):755-766.

PMID: 39098717 PMC: 11738786. DOI: 10.1016/j.virs.2024.08.001.


Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.

Pluta R, Bogucka-Kocka A, Bogucki J, Kocki J, Czuczwar S J Alzheimers Dis. 2024; 99(4):1375-1383.

PMID: 38759019 PMC: 11191440. DOI: 10.3233/JAD-240401.


Identification of in the Potential Treatment of Alzheimer's Disease by Integrating Virtual Screening and In Vitro Validation.

Jiang S, Borjigin G, Sun J, Li Q, Wang Q, Mu Y Int J Mol Sci. 2023; 24(20).

PMID: 37895137 PMC: 10607254. DOI: 10.3390/ijms242015457.


Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?.

Tarawneh R Biomolecules. 2023; 13(5).

PMID: 37238700 PMC: 10216678. DOI: 10.3390/biom13050830.


Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease.

Salasova A, Monti G, Andersen O, Nykjaer A Mol Neurodegener. 2022; 17(1):74.

PMID: 36397124 PMC: 9673319. DOI: 10.1186/s13024-022-00576-2.


References
1.
Yang L, Lindholm K, Yan R, Citron M, Xia W, Yang X . Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med. 2003; 9(1):3-4. DOI: 10.1038/nm0103-3. View

2.
Snowdon D, Greiner L, Mortimer J, Riley K, Greiner P, Markesbery W . Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997; 277(10):813-7. View

3.
Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli K . Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci. 1998; 18(10):3659-68. PMC: 6793169. View

4.
Gervais F, Xu D, Robertson G, Vaillancourt J, Zhu Y, Huang J . Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell. 1999; 97(3):395-406. DOI: 10.1016/s0092-8674(00)80748-5. View

5.
Leblanc A, Liu H, Goodyer C, Bergeron C, Hammond J . Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem. 1999; 274(33):23426-36. DOI: 10.1074/jbc.274.33.23426. View